Syndecan-1 deficiency promotes tumor growth in a murine model of colitis-induced colon carcinoma

• Adi Binder Gallimidi,

  Affiliation Sharett Oncology Institute, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

  ⨯
• Gabriel Nussbaum,

  Affiliation Institute of Dental Sciences, Hebrew University-Hadassah Faculty of Dental Medicine, Jerusalem, Israel

  ⨯
• Esther Hermano,

  Affiliation Sharett Oncology Institute, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

  ⨯
• Barak Weizman,

  Affiliation Sharett Oncology Institute, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

  ⨯
• Amichay Meirovitz,

  Affiliation Sharett Oncology Institute, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

  ⨯
• Israel Vlodavsky,

  Affiliation Cancer and Vascular Biology Research Center, The Rappaport Faculty of Medicine, Technion, Haifa, Israel

  ⨯
• Martin Götte,

  Affiliation Department of Gynecology and Obstetrics, Muenster University, Medical Center, Muenster Germany

  ⨯
• Michael Elkin

  * E-mail: melkin@hadassah.org.il

  Affiliation Sharett Oncology Institute, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

  ⨯